113 related articles for article (PubMed ID: 3578255)
1. Prediction of cardiovascular complications in patients with prostatic cancer treated with estrogen.
Henriksson P; Johansson SE
Am J Epidemiol; 1987 Jun; 125(6):970-8. PubMed ID: 3578255
[TBL] [Abstract][Full Text] [Related]
2. Patients at high risk of cardiovascular complications in oestrogen treatment of prostatic cancer.
Henriksson P; Edhag O; Eriksson A; Johansson SE
Br J Urol; 1989 Feb; 63(2):186-90. PubMed ID: 2649197
[TBL] [Abstract][Full Text] [Related]
3. Deleterious effects of low-dose oestrogen therapy on coronary status in patients with prostatic cancer.
Henriksson P; Linde B; Edhag O
Eur Heart J; 1987 Jul; 8(7):779-84. PubMed ID: 3653128
[TBL] [Abstract][Full Text] [Related]
4. High dose polyoestradiol phosphate with and without acetosalicylic acid versus orchiectomy in the treatment of prostatic cancer. Finnprostate Group.
Aro JL; Haapiainen RK; Rannikko SA; Alfthan OS
Br J Urol; 1989 May; 63(5):512-4. PubMed ID: 2659136
[TBL] [Abstract][Full Text] [Related]
5. Cardiovascular complications of estrogen therapy for nondisseminated prostatic carcinoma. A preliminary report from a randomized multicenter study.
Lundgren R; Sundin T; Colleen S; Lindstedt E; Wadström L; Carlsson S; Hellsten S; Pompeius R; Holmquist B; Nilsson T
Scand J Urol Nephrol; 1986; 20(2):101-5. PubMed ID: 3529368
[TBL] [Abstract][Full Text] [Related]
6. Orchiectomy, estrogen therapy and radiotherapy in locally advanced (T3-4 M0) prostatic cancer.
Aro J; Haapiainen R; Kajanti M; Rannikko S; Alfthan O
Scand J Urol Nephrol Suppl; 1988; 110():103-7. PubMed ID: 3187397
[TBL] [Abstract][Full Text] [Related]
7. Cardiovascular and all-cause mortality in prostatic cancer patients treated with estrogens or orchiectomy as compared to the standard population.
Aro J
Prostate; 1991; 18(2):131-7. PubMed ID: 2006119
[TBL] [Abstract][Full Text] [Related]
8. Parenteral polyoestradiol phosphate vs orchidectomy in the treatment of advanced prostatic cancer. Efficacy and cardiovascular complications: a 2-year follow-up report of a national, prospective prostatic cancer study. Finnprostate Group.
Mikkola AK; Ruutu ML; Aro JL; Rannikko SA; Salo JO
Br J Urol; 1998 Jul; 82(1):63-8. PubMed ID: 9698663
[TBL] [Abstract][Full Text] [Related]
9. Comparison of endocrine and radiation therapy in locally advanced prostatic cancer.
Aro J; Haapiainen R; Kajanti M; Rannikko S; Alfthan O
Eur Urol; 1988; 15(3-4):182-6. PubMed ID: 3063541
[TBL] [Abstract][Full Text] [Related]
10. Parenteral estrogen versus combined androgen deprivation in the treatment of metastatic prostatic cancer -- Scandinavian Prostatic Cancer Group (SPCG) Study No. 5.
Hedlund PO; Ala-Opas M; Brekkan E; Damber JE; Damber L; Hagerman I; Haukaas S; Henriksson P; Iversen P; Pousette A; Rasmussen F; Salo J; Vaage S; Varenhorst E;
Scand J Urol Nephrol; 2002; 36(6):405-13. PubMed ID: 12623503
[TBL] [Abstract][Full Text] [Related]
11. Comparison of primary orchiectomy with oestrogen therapy in advanced prostatic cancer. A 2-year follow-up report of a national, prospective prostatic cancer study.
Haapiainen R; Rannikko S; Alfthan O
Br J Urol; 1986 Oct; 58(5):528-33. PubMed ID: 3779355
[TBL] [Abstract][Full Text] [Related]
12. Parenteral estrogen versus total androgen ablation in the treatment of advanced prostate carcinoma: effects on overall survival and cardiovascular mortality. The Scandinavian Prostatic Cancer Group (SPCG)-5 Trial Study.
Hedlund PO; Henriksson P
Urology; 2000 Mar; 55(3):328-33. PubMed ID: 10699602
[TBL] [Abstract][Full Text] [Related]
13. Adrenocortical function in prostatic cancer patients: effects of orchidectomy or different modes of estrogen treatment on basal steroid levels and on the response to exogenous adrenocorticotropic hormone.
Carlström K; Stege R
Urol Int; 1990; 45(3):160-3. PubMed ID: 2161578
[TBL] [Abstract][Full Text] [Related]
14. Primary orchiectomy versus estrogen therapy in advanced prostatic cancer--a randomized study: results after 7 to 10 years of followup.
Johansson JE; Andersson SO; Holmberg L; Bergström R
J Urol; 1991 Mar; 145(3):519-22; discussion 522-3. PubMed ID: 1997702
[TBL] [Abstract][Full Text] [Related]
15. The effect of parenteral estrogen versus orchiectomy on blood coagulation and fibrinolysis in prostatic cancer patients.
Aro J; Haapiainen R; Rasi V; Rannikko S; Alfthan O
Eur Urol; 1990; 17(2):161-5. PubMed ID: 2178941
[TBL] [Abstract][Full Text] [Related]
16. Cardiovascular follow-up of patients with prostatic cancer treated with single-drug polyestradiol phosphate.
Henriksson P; Eriksson A; Stege R; Collste L; Pousette A; von Schoultz B; Carlström K
Prostate; 1988; 13(3):257-61. PubMed ID: 3211807
[TBL] [Abstract][Full Text] [Related]
17. Effects of orchidectomy and different modes of high dose estrogen treatment on circulating "free" and total 1,25-dihydroxyvitamin D in patients with prostatic cancer.
Hagenfeldt Y; Carlström K; Berlin T; Stege R
J Steroid Biochem Mol Biol; 1991 Aug; 39(2):155-9. PubMed ID: 1888674
[TBL] [Abstract][Full Text] [Related]
18. Correlation of pretreatment plasma levels of estradiol and sex-hormone-binding globulin-binding capacity with clinical stage and survival of patients with prostatic cancer.
Haapiainen R; Rannikko S; Adlercreutz H; Alfthan O
Prostate; 1986; 8(2):127-37. PubMed ID: 3952023
[TBL] [Abstract][Full Text] [Related]
19. Bone mineral density in patients with prostatic cancer treated with orchidectomy and with estrogens.
Eriksson S; Eriksson A; Stege R; Carlström K
Calcif Tissue Int; 1995 Aug; 57(2):97-9. PubMed ID: 7584882
[TBL] [Abstract][Full Text] [Related]
20. Treatment of prostatic cancer: effects on serum lipoproteins and the cardiovascular system.
Rössner S; Hedlund PO; Jogestrand T; Säwe U
J Urol; 1985 Jan; 133(1):53-7. PubMed ID: 3964880
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
